Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars

• Asıl Yazarlar: Alina Uifălean (Yazar), Maria Ilieş (Yazar), Raul Nicoară (Yazar), Lucia Maria Rus (Yazar), Simona Codruţa Hegheş (Yazar), Cristina-Adela Iuga (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2018-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

With the development of anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibodies, trastuzumab-based therapy has become the standard of care among patients with early or advanced HER2-positive breast cancer. However, real-world data have shown that up to a half of patients do not re...